Category Archives: Ethics, Research & Health


Scientific research and technological development make a major contribution to the integral development and the quality of life of human beings, especially, but not only, in the area of health where new therapeutic options become increasingly available. They are also an important motor of economic growth. COMECE chiefly covers the bioethical issues that arise at the EU level in the ambits of health and of research, although the main competences with regard to these matters remain largely at the Member States’ level. COMECE is assisted in this mission by a Working Group on Ethics.
Ethics, Research & Health, Policy Areas, Press

News

Gestational Surrogacy: a frontal assault on fundamental shared EU values

Gestational surrogacy is an issue of increasing preoccupation and concern in contemporary political and legal debate across the European Union. Against that background, the COMECE Working Group on Ethics in Research and Medicine has published an “Opinion on Gestational Surrogacy: the question of European and International Rules” , which is presented today, 23 February, at an event hosted by MEP Miroslav Mikolasik at the European … Continue reading »

Ethics, Research & Health, Policy Areas, Press

Press Release

COMECE Secretariat regrets EU Commission’s decision on the ‘One of Us’ citizens’ initiative

The European Commission decided on 28 May not to submit any legislative proposal as a reply to the European Citizens Initiative ‘One of Us’. This initiative asked for the ending of the EU financing of activities which presuppose the destruction of human embryos, in particular in the areas of research (projects making use of human embryonic stem cells – hESC) and development cooperation (abortion, either … Continue reading »

Ethics, Research & Health, Policy Areas, Press

News

Horizon 2020 : The EU should not fund research on human embryonic stem cells

The success of the recent citizens initiative “One of Us” finally ought to convince the EU Parliament to end the financing of research activities which presuppose the destruction of human embryos. The EU should not ignore the will of nearly 1.9 million EU citizens who signed this initiative. The European Parliament is about to vote on “Horizon 2020”, the European Union’s new programme for research … Continue reading »

Ethics, Research & Health, Policy Areas, Press

News

Do not be misled: abortion is not a EU competence

In the context of the Vote today at the European Parliament of an own initiative Report on “Sexual and Reproductive Health and Rights” which includes abortion, COMECE recalls that the EU has no competence in regard to this matter. EU citizens should not be misled. Article 168 § 7of the Treaty on the Functioning of the EU states that the ‘‘Union action shall respect the … Continue reading »

Ethics, Research & Health, Policy Areas, Press

News

COMECE’s Opinion on Medical Devices: Not safe enough

In an Opinion published today, the COMECE Reflection Group on Bioethics, while welcoming the ongoing revision of European legislation on Medical Devices, warns against some ethical shortcomings and proposes improvements to Proposals which will be voted in the Environment, Public Health and Food Safety Committee of the European Parliament on 18 September. There are currently around half a million medical devices (MDs) on the market … Continue reading »

Ethics, Research & Health, Policy Areas, Press

News

Clinical trials on medicinal products for human use in the EU: A sound ethical framework is essential

Clinical trials are necessary before any new medicine is put on the market. However, many people who are unable to give consent as well as people from less-developed countries often participate in such trials. So how can we better protect these people and vulnerable populations against abuse? The European Commission has proposed a regulation which will be submitted to a vote of the European Parliament … Continue reading »

Ethics, Research & Health, Policy Areas, Press

News

COMECE welcomes today’s announcement of the Nobel Prize for Medicine for research on alternatives to embryonic stem cells research

In contrast, there have been continuing scientific advances in fields of research involving alternative stem cells (adult, derived from umbilical cord or induced pluripotent) which present better prospects for clinical applications; or have indeed already demonstrated widespread clinical results (and do not raise any special ethical problems). Today’s Nobel Prize rewards such efforts to discover alternatives to hESC in mature, specialised cells that once reprogrammed … Continue reading »